News & Blog

Press Release: Graviton BioScience Announces Clearance of Investigational New Drug (IND) for GV101 for the Treatment of Friedreich’s Ataxia

August 2026 – Advocacy Newsletter

Meet The Community: Antonio José Matos Moreira

Community Statement: Update from Biogen

Meet The Community: Donovan Simpson

Meet The Community: Savannah Glenn

Press Release: Cellares and Papillon Therapeutics Partner to Automate Manufacturing of PPL-001 for Patients With Friedreich’s Ataxia

Meet The Community: Hayden Howard

Community Statement: Update from Biogen

Meet the 2026 FARA Fellows

Meet The Community: Kanhaiya Lal Kumawat

July 2026 – Advocacy Newsletter